Skip to content

Assessment of the 90-day Mortality Risk Score After VATS Lobectomy

Assessment of the 90-day Mortality Risk Score After Video-assisted Thoracoscopic Lobectomy in the Italian VATS Group Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04799509
Enrollment
2209
Registered
2021-03-16
Start date
2014-01-01
Completion date
2018-11-27
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Morality, Surgery--Complications

Keywords

non-small cell lung cancer, VATS lobectomy, 90-day postoperative mortality, risk score, validation

Brief summary

A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3 points), carbon monoxide lung diffusion capacity \<60% (1 point) and operative time \>150 minutes (1 point), has been recently published. This study aims to assess the effectiveness and reliability of this risk model in a large, independent cohort of patients, in order to confirm its generalizability.

Detailed description

From the Italian VATS Group Database, we selected patients who underwent video-assisted thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk score and the corresponding class of 90-day mortality risk for each patient. The correlation between risk classes and mortality rates was tested by Spearman's rho-test. Model calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test.

Interventions

VATS lobectomy

Sponsors

Università degli Studi dell'Insubria
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- Patients undergoing VATS lobectomy for non-small cell lung cancer

Exclusion criteria

* Incomplete data for risk score calculation * Tumor size \>5 cm * Follow-up \<3 months * Patients undergoing neoadjuvant treatment * Patients undergoing extended resection

Design outcomes

Primary

MeasureTime frameDescription
90-day postoperative mortality90 day post surgical procedureAlive/Death (cause of death)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026